Delivery Order SPE2DB20D3103-SPE2DB24FM0Y2
Award Date 12/28/23
Potential Completion Date 12/29/23
Potential Value $16K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $31,234.56 firm fixed-price contract is for the delivery of 16,000 units of the drug Pertzye DR 250S capsules. The contract has a completion date of November 15, 2023 and was awarded on November 14, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- The Defense Logistics Agency awarded a $2,136.78 delivery order to AmerisourceBergen Drug Corp for 16,000 unit capsules of Pertzye (pancrelipase) on January 13, 2026, with an ultimate completion date of January 14, 2026. This is a non-set-aside, competitively awarded contract utilizing firm fixed pricing. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, while its parent organization is Cencora, Inc. (doing business as AmerisourceBergen)....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 16,000 unit capsules of the medication Pertzye DR, a pancreatic enzyme replacement therapy, at a firm fixed price of $10,241.07. The contract has an ultimate completion date of May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,333.24, is for the delivery of 24,000 units of the medication Pertzye DR 80S capsules. The contract is a firm fixed-price delivery order with a completion date of March 20, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 16,000 units of Pertzye capsules (pancrelipase 16,000 USP units) valued at $8,939.24 under a firm fixed price contract. This non-set-aside award, issued on August 28, 2025, with completion targeted for August 29, 2025, represents a routine pharmaceutical procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The $5,738.32 firm-fixed-price contract is for the supply of 16,000 units of the pharmaceutical product PERTZYE DR 250S capsules. The contract has an ultimate completion date of August 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, regularly fulfills federal contracts to provide a wide range of prescription medications, medical supplies, and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,348.76 from the Defense Logistics Agency (DLA) on September 9, 2025, with an ultimate completion date of September 10, 2025. The award is for 16,000 unit capsules of Pertzye DR 100s, a pancreatic enzyme replacement therapy used to treat pancreatic insufficiency. This delivery order was competitively awarded with no set-aside designation and carries...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,946.55 to AmerisourceBergen Drug Corp for 16,000 unit capsules of Pertzye DR 100s. This is a firm fixed price, non-set-aside contract awarded on August 4, 2025, with an ultimate completion date of August 5, 2025. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $5,371.56 to AmerisourceBergen Drug Corp for 16,000 unit capsules of Pertzye DR 100s, a pancreatic enzyme replacement therapy. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on December 9, 2025, with an ultimate completion date of December 10, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- This federal contract award, valued at $10,060.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 24,000 units of the drug Pertzye DR 200mg Capsule, a medication used for the treatment of pancreatic exocrine insufficiency. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of February 14, 2024. This award is not associated...